Lini Pandite

3PUBLICATIONS
12CO-AUTHORS
Infectious agentsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 27, 2026
Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease.

|Apr 08, 2026
Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.

Yvette Drew, Lucy Gilbert, Alejandro Martinez Bueno

|Jan 12, 2025
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer.

Nehal J Lakhani, Daphne Stewart, Debra L Richardson

Pageof 1

Frequent Collaborators

1 joint publications

Nehal J Lakhani

1 joint publications

Debra L Richardson

1 joint publications

Yvette Drew

1 joint publications

Ana Oaknin